These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17114083)

  • 1. PET in face and neck tumours.
    Rankin SC
    Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The rationale for imaging methods in head and neck oncology].
    Westhofen M
    Laryngorhinootologie; 2006 Oct; 85(10):720-2. PubMed ID: 17031762
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
    de Casso C; Visvanathan V; Soni-Jaiswall A; Kane T; Nigam A
    J Laryngol Otol; 2012 Mar; 126(3):295-301. PubMed ID: 22251666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in cancer of the head and neck.
    Hain SF
    Br J Oral Maxillofac Surg; 2005 Feb; 43(1):1-6. PubMed ID: 15620766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
    Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):748-52. PubMed ID: 22911297
    [No Abstract]   [Full Text] [Related]  

  • 6. A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
    Zollinger LV; Wiggins RH
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):754-8. PubMed ID: 22911298
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
    Ekberg T; Sörensen J; Engström M; Blomquist E; Sundin A; Anniko M
    Acta Otolaryngol; 2007 Feb; 127(2):186-93. PubMed ID: 17364351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
    Schwartz DL; Macapinlac HA; Weber RS
    J Natl Cancer Inst; 2008 May; 100(10):688-9. PubMed ID: 18477798
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
    Manolidis S; Donald PJ; Volk P; Pounds TR
    Acta Otolaryngol Suppl; 1998; 534():1-11. PubMed ID: 9726577
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
    Pai M; Park CH; Suh JH; Koh JH
    Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
    Hanasono MM; Kunda LD; Segall GM; Ku GH; Terris DJ
    Laryngoscope; 1999 Jun; 109(6):880-5. PubMed ID: 10369275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
    Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
    Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional imaging in head and neck cancer.
    Kutler DI; Wong RJ; Kraus DH
    Curr Oncol Rep; 2005 Mar; 7(2):137-44. PubMed ID: 15717948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
    Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
    Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of image fusion from MR and PET in patients with head and neck cancer.
    Nakamoto Y; Tamai K; Saga T; Higashi T; Hara T; Suga T; Koyama T; Togashi K
    Mol Imaging Biol; 2009; 11(1):46-53. PubMed ID: 18769975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
    de Bree R
    Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1653-5. PubMed ID: 20827553
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.